In untreated MG patients, FAS mRNA levels were lower in GCs than in the corresponding WS-GCs (Figure 2C), sustaining the hypothesis of a miR-146a contribution to GC formation via Fas downregulation in B cells. This evidence concerns the gene FAS and myasthenia gravis.